01/15
Cabrita R et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. ➔

01/15
Helmink B et al. B cells and tertiary lymphoid structures promote immunotherapy response. ➔

12/26
Rozeman EA et al., Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM). ➔

12/12
Farren MR et al., Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemo- and radiotherapy. ➔